Evonik Industries AG's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 43.92.
Evonik Industries AG's Days Inventory for the
three
months ended in Mar. 2026 was 85.22.
Evonik Industries AG's Days Payable for the
three
months ended in Mar. 2026 was 52.64.
Therefore, Evonik Industries AG's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 76.50.
Evonik Industries AG (XSWX:EVK) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Evonik Industries AG Cash Conversion Cycle Related Terms
Evonik Industries AG Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Evonik Industries AG's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:EVK vs LIN, SHW, ECL: Cash Conversion Cycle Comparison
For the Specialty Chemicals subindustry, Evonik Industries AG's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG Cash Conversion Cycle vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's Cash Conversion Cycle falls into.
Evonik Industries AG Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Evonik Industries AG's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evonik Industries AG (XSWX:EVK) has a Cash Conversion Cycle of 76.50 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Evonik Industries AG and its competitors.
Is Evonik Industries AG's Cash Conversion Cycle too high?
Evonik Industries AG's current Cash Conversion Cycle is 76.50. The Chemicals industry median Cash Conversion Cycle is 89.20. Evonik Industries AG's value of 76.50 is 14.2% below this industry median. Overall, Evonik Industries AG has a GF Score™ of 16/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Cash Conversion Cycle compare to LIN and SHW?
Evonik Industries AG's Cash Conversion Cycle of 76.50 can be compared against companies in the Chemicals industry. The industry median Cash Conversion Cycle is 89.20. Evonik Industries AG's value of 76.50 is 14.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Chemicals company?
The median Cash Conversion Cycle among Chemicals companies is 89.20, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evonik Industries AG's current Cash Conversion Cycle of 76.50 is 14.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Evonik Industries AG and its competitors. For the Chemicals industry, the median Cash Conversion Cycle is 89.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evonik Industries AG's current Cash Conversion Cycle is 76.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (XSWX:EVK) is currently considered Fairly Valued. The stock's GF Value™ is CHF14.66, compared to a current price of CHF14.54 — trading 0.8% below its estimated fair value. The current Cash Conversion Cycle is 76.50 and 14.2% below the Chemicals industry median of 89.20. Evonik Industries AG's overall GF Score™ is 16/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Cash Conversion Cycle is 76.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be undervalued.
The current stock price of CHF14.54 is trading 0.8% below its estimated GF Value™ of CHF14.66.
GuruFocus considers Evonik Industries AG to be Fairly Valued.
Key valuation signals for XSWX:EVK:
Cash Conversion Cycle: 76.50
GF Value™: CHF14.66 vs. price of CHF14.54 (0.8% below fair value)
Industry Position: 14.2% below the Chemicals median
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
16GF Score
Get the complete analysis for XSWX:EVK
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
